Kyrgyzstan faces several issues related to access to medicines, including limited affordability and availability, especially of medicines for chronic diseases. There is also a problem with low quality medicines entering the country through informal channels. The MeTA program in Kyrgyzstan aims to address these issues by improving information sharing between organizations, disseminating information to the public, and encouraging collaboration between the government, private sector, and civil society organizations.